144 related articles for article (PubMed ID: 10923106)
1. Burkitt's lymphoma: molecular pathogenesis and treatment.
Bishop PC; Rao VK; Wilson WH
Cancer Invest; 2000; 18(6):574-83. PubMed ID: 10923106
[No Abstract] [Full Text] [Related]
2. EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt's lymphoma.
Zimber-Strobl U; Strobl L; Höfelmayr H; Kempkes B; Staege MS; Laux G; Christoph B; Polack A; Bornkamm GW
Curr Top Microbiol Immunol; 1999; 246():315-20; discussion 321. PubMed ID: 10396071
[No Abstract] [Full Text] [Related]
3. Biology and treatment of Burkitt's lymphoma.
Yustein JT; Dang CV
Curr Opin Hematol; 2007 Jul; 14(4):375-81. PubMed ID: 17534164
[TBL] [Abstract][Full Text] [Related]
4. [Human immunodeficiency virus/acquired immunodeficiency syndrome-related Burkitt's lymphoma: report of two cases].
Shao ZT; Pan Y; Li ZJ; Tian LB; Wang M; Bi L; Li YK
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):408-10. PubMed ID: 22932411
[No Abstract] [Full Text] [Related]
5. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
6. [Burkitt's lymphoma with atypical cutaneous lesion in an HIV-infected patient].
Calza L; Manfredi R; Chiodo F
Presse Med; 2001 Oct; 30(31 Pt 1):1552-3. PubMed ID: 11721496
[No Abstract] [Full Text] [Related]
7. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
[TBL] [Abstract][Full Text] [Related]
8. Significance of chromosome 8 breakpoint location in Burkitt's lymphoma: correlation with geographical origin and association with Epstein-Barr virus.
Barriga F; Kiwanuka J; Alvarez-Mon M; Shiramizu B; Huber B; Levine P; Magrath I
Curr Top Microbiol Immunol; 1988; 141():128-37. PubMed ID: 2850892
[No Abstract] [Full Text] [Related]
9. Deregulated c-myc gene expression and persistence of EBV are not sufficient to maintain the malignant phenotype in Burkitt's lymphoma x B-lymphoblastoid hybrid cells.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Curr Top Microbiol Immunol; 1990; 166():333-6. PubMed ID: 1963583
[No Abstract] [Full Text] [Related]
10. Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements.
Campomenosi P; Fronza G; Ottaggio L; Roncella S; Inga A; Bogliolo M; Monti P; Assereto P; Moro F; Cutrona G; Bozzo S; Chiorazzi N; Abbondandolo A; Ferrarini M
Int J Cancer; 1997 Dec; 73(6):816-21. PubMed ID: 9399658
[TBL] [Abstract][Full Text] [Related]
11. The etiology of Burkitt's lymphoma and the history of the shaken dogmas.
de Thé G
Blood Cells; 1993; 19(3):667-73; discussion 674-5. PubMed ID: 8018947
[TBL] [Abstract][Full Text] [Related]
12. Cofactors in disease: Epstein-Barr virus, oncogenes, and Burkitt's lymphoma.
Spriggs DR
J Infect Dis; 1985 May; 151(5):977-8. PubMed ID: 2985714
[No Abstract] [Full Text] [Related]
13. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
14. What is Burkitt's lymphoma?
Wright DH
J Pathol; 1997 Jun; 182(2):125-7. PubMed ID: 9274520
[TBL] [Abstract][Full Text] [Related]
15. EBV and Burkitt's lymphoma.
Rossi G; Bonetti F
N Engl J Med; 2004 Jun; 350(25):2621; author reply 2621. PubMed ID: 15201422
[No Abstract] [Full Text] [Related]
16. Burkitt's lymphoma: new insights into molecular pathogenesis.
Bellan C; Lazzi S; De Falco G; Nyongo A; Giordano A; Leoncini L
J Clin Pathol; 2003 Mar; 56(3):188-92. PubMed ID: 12610094
[TBL] [Abstract][Full Text] [Related]
17. Approach to the Diagnosis and Treatment of Adult Burkitt's Lymphoma.
Dunleavy K
J Oncol Pract; 2018 Nov; 14(11):665-671. PubMed ID: 30423267
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin VH3-positive AIDS-related Burkitt's lymphoma: a possible role for the HIV gp120 superantigen.
Amariglio N; Vonsover A; Hakim I; Neumann Y; Mark Z; Brok-Simoni F; Ben-Bassat I; Rechavi G
Acta Haematol; 1994; 91(2):103-5. PubMed ID: 8023641
[No Abstract] [Full Text] [Related]
19. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: implications for their pathogenesis.
Dis Markers; 1990; 8(3):162. PubMed ID: 2176940
[No Abstract] [Full Text] [Related]
20. Sporadic Burkitt's lymphoma of the head and neck in the pediatric population.
Banthia V; Jen A; Kacker A
Int J Pediatr Otorhinolaryngol; 2003 Jan; 67(1):59-65. PubMed ID: 12560151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
